PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3)
To Prospectus Dated July 31, 1997, Registration No. 333-31973
As Supplemented to Date
1,657,560 Shares
PHYMATRIX CORP.
Common Stock
This Prospectus Supplement (the "Supplement") relates to up to 30,337
shares (the "Shares") of Common Stock, par value $.01 per share, of PhyMatrix
Corp., a Delaware corporation (the "Company"), which may be offered and sold by
Eugene D. Davidson (the "Selling Stockholders") pursuant to the Company's
Registration Statement on Form S-3 (No. 333-31973) (the "Registration
Statement"). This Supplement should be read in conjunction with the Prospectus
dated July 31, 1997, which is a part of the Registration Statement, as such
Prospectus may have been supplemented to date (the "Prospectus"). A copy of the
Prospectus accompanies this Supplement. All capitalized terms used but not
defined in this Supplement shall have the meanings given them in the Prospectus.
The Shares were acquired by the Selling Shareholders under the terms of the
Company's acquisition on July 1, 1996 of the assets of Georgia Surgical
Associates, P.C. (the "Practice"), of which the Selling Shareholders were the
sole stockholders. To the Company's knowledge, the Shares which may be offered
represent all the shares of Common Stock owned by the Selling Stockholders. If
all of such Shares are sold, none of the Selling Stockholders will hold any
shares of Common Stock of the Company.
The closing price of the Company's Common Stock as reported on The Nasdaq
National Market on August 14, 1997 was $12.9375 per share.
The date of this Prospectus Supplement is August 15, 1997.
